Who is the CEO of Satellos Bioscience Inc.?

The CEO of Satellos Bioscience Inc. is Francis Gleeson.

What industry does Satellos Bioscience Inc. belong to?

Satellos Bioscience Inc. operates in the Biotechnology industry within the Healthcare sector.

Where is Satellos Bioscience Inc. headquartered?

Satellos Bioscience Inc. is headquartered at Royal Bank Plaza, Toronto, ON, M5J 2J1, CA.

What is the IPO date of Satellos Bioscience Inc.?

Satellos Bioscience Inc. went public on January 7, 2008.

How many employees does Satellos Bioscience Inc. have?

Satellos Bioscience Inc. has approximately 14 full-time employees.

Satellos Bioscience Inc.

MSCL.TO•TSX

Healthcare

Biotechnology

CA$0.59

CA$0.01(1.72%)

Satellos Bioscience Inc. (MSCL.TO) Company Profile & Overview

Explore Satellos Bioscience Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Satellos Bioscience Inc. (MSCL.TO) Company Profile & Overview

Satellos Bioscience Inc., a biotechnology company, develops regenerative therapeutics to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system which recapitulates the muscle stem cell environment ex-vivo. Its lead program focuses on the discovery and development of a small molecule drug for the treatment of Duchenne. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

SectorHealthcare

IndustryBiotechnology

CEOFrancis Gleeson

Contact Information

https://satellos.com

Royal Bank Plaza, Toronto, ON, M5J 2J1

Company Facts

14 Employees

IPO DateJan 7, 2008

CountryCA

Actively Trading

Frequently Asked Questions

;